Table 1 Characteristics of women treated for osteoporosis at the time of the consultation (questionnaire population; N = 785).
Patient characteristics | Treatments | ||
|---|---|---|---|
Age (years) | 66.30 ± 9.07 | Daily bisphosphonates | 17 (2.2%) |
Age at menopause (years) | 49.75 ± 3.97 | Weekly bisphosphonates | 305 (40.6%) |
Time since menopause (years) | 16.49 ± 9.38 | Monthly bisphosphonates | 202 (26.9%) |
Densitometry in the last six months | 667 (85.3%) | SERMs | 76 (10.1%) |
Osteoporotic fractures | 389 (51.7%) | Strontium ranelate | 119 (15.8%) |
At least one risk factor | 618 (78.7%) | Others | 26 (3.5%) |